Assembly Biosciences (ASMB) Interest Coverage Ratio (2010 - 2025)
Assembly Biosciences' (ASMB) quarterly Interest Coverage Ratio came in at 1.15 in Q4 2025, up 2210.45% year-on-year from 0.05 in Q4 2024, and up 2210.45% quarter-over-quarter from 0.05 in Q4 2024.
Assembly Biosciences (ASMB) Interest Coverage Ratio (2010 - 2025) Analysis & Trends
Assembly Biosciences' Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 1.15 for Q4 2025.
- On a quarterly basis, Interest Coverage Ratio rose 2210.45% year-over-year to 1.15 in Q4 2025; TTM through Dec 2025 was 0.7, a 227.96% decrease from a year earlier, with the FY2025 full-year figure at 0.7, down 227.96% from the prior year.
- Interest Coverage Ratio climbed to 1.15 in Q4 2025 per ASMB's latest filing, from 0.05 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 1.15 in Q4 2025 and bottomed at 23401.0 in Q3 2022.
- The 5-year median for Interest Coverage Ratio is 23.11 (2021), against an average of 2221.27.
- Across the five-year window, Interest Coverage Ratio slumped 1000904.9% in 2022 and jumped 2210.45% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 67.62 in 2021, then jumped by 75.23% to 16.75 in 2022, then tumbled by 3844.27% to 660.58 in 2023, then surged by 99.99% to 0.05 in 2024, then soared by 2210.45% to 1.15 in 2025.
- Per Business Quant, the three latest ASMB Interest Coverage Ratio figures stand at 1.15 (Q4 2025), 0.05 (Q4 2024), and 660.58 (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Assembly Biosciences | 282.74 Mn | 56.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.15 |
| Dec 31, 2024 | -0.05 |
| Dec 31, 2023 | -660.58 |
| Dec 31, 2022 | -16.75 |
| Sep 30, 2022 | -23,401.00 |
| Jun 30, 2022 | -101.12 |
| Mar 31, 2022 | -142.98 |
| Dec 31, 2021 | -67.62 |
| Sep 30, 2021 | -2.34 |
| Jun 30, 2021 | -23.11 |
| Mar 31, 2021 | -19.57 |
| Dec 31, 2020 | -35.05 |
| Sep 30, 2020 | -0.15 |
| Jun 30, 2020 | 0.10 |
| Mar 31, 2020 | -1.29 |
| Dec 31, 2019 | -26.53 |
| Sep 30, 2019 | -2.89 |
| Jun 30, 2019 | -1.01 |
| Mar 31, 2019 | -27.32 |
| Dec 31, 2018 | -0.30 |